2026 NPPES data Dermatology Physician NPI 1346635406 MD
Verify on CMS →

MATTHEW REEDY, MD

Dermatology Physician in MEDINA, Ohio. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 707 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$18.1K
228 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MATTHEW REEDY, MD reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 1,871 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
2K
Part D claims, 2023
87%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MATTHEW REEDY, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MATTHEW REEDY, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MATTHEW REEDY, MD?

Below national average

NPI registry status

Active

Issued 04/05/2015

NPI 1346635406

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

1,871 157% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Ohio

How Dermatology Physician compares to other specialties among Ohio providers

Ohio providers

Dermatology Physician share within Ohio

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Ohio

Medicare quality performance — MIPS

MATTHEW REEDY, MD's 2023 MIPS final score plotted against the Dermatology Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Dermatology Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MATTHEW REEDY, MD appears in the CMS NPPES registry as a Dermatology Physician provider holding MD credentials at 5783 WOOSTER PIKE, MEDINA, OH, 44256, with a listed phone of (330) 725-0569. NPI 1346635406 was issued on 04/05/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what REEDY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,871 prescription claims written by this provider, covering 707 Medicare beneficiaries and totaling roughly $1.3 million in drug spend, split 13% brand-name and 87% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5783 WOOSTER PIKE
MEDINA, OH 44256

Provider Details

NPI 1346635406
Specialty Dermatology Physician
Credentials MD
Gender Male
NPI Issued 04/05/2015

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Group practice

Hospital and facility affiliations

Facilities where MATTHEW REEDY, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

HMT DERMATOLOGY ASSOCIATES INC.
MEDINA, OH

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MATTHEW REEDY, MD. Source: openpaymentsdata.cms.gov.

Total received

$18.1K

Largest payer

LEO Pharma Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Ohio OMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 — they are NOT specific to MATTHEW REEDY, MD. To verify MATTHEW REEDY, MD's current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

158
Total board actions, Ohio 2023
Across 154 cases
3.29
Actions per 1,000 licensees
Ohio statewide rate
probation
Most common action type
56 cases

OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MATTHEW REEDY, MD — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 1,871 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,871
Total Claims
$1.3M
Total Drug Cost
707
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,241
Total Day Supply
60,766
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$1.2M
Generic Drug Cost
$73K
Antibiotic Claims
159

Patient Demographics

Average Patient Age
73.8 years
Avg HCC Risk Score
1.16
Gender Split
47% female / 53% male
Age Distribution
<65: 49, 65-74: 352, 75-84: 226, 85+: 80

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MATTHEW REEDY, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Clobetasol Propionate
306
Ketoconazole
299
Triamcinolone Acetonide
251
Doxycycline Monohydrate
148
Fluorouracil
78
Betamethasone Diprop Augmented
Betamethasone/Propylene Glyc
56
Metronidazole
51
Dupixent Pen
Dupilumab
47
Prednisone
46
Dupixent Syringe
Dupilumab
42

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How MATTHEW REEDY, MD fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

MATTHEW REEDY, MD's 1,871 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in Ohio

Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as REEDY.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MATTHEW REEDY, MD's specialty?
MATTHEW REEDY, MD specializes in Dermatology Physician and practices in MEDINA, Ohio. Credentials: MD.
How much does MATTHEW REEDY, MD prescribe under Medicare Part D?
In 2023, MATTHEW REEDY, MD wrote 1,871 Medicare Part D claims totaling $1.3M in drug costs for 707 beneficiaries.
What is MATTHEW REEDY, MD's Medicare quality score?
MATTHEW REEDY, MD has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MATTHEW REEDY, MD located?
MATTHEW REEDY, MD is located at 5783 WOOSTER PIKE, MEDINA, OH, 44256. Phone: (330) 725-0569.
What is MATTHEW REEDY, MD's NPI number?
MATTHEW REEDY, MD's National Provider Identifier (NPI) is 1346635406, issued on 04/05/2015.
Does MATTHEW REEDY, MD prescribe more brand-name or generic drugs?
MATTHEW REEDY, MD's prescribing is 13% brand-name and 87% generic drugs by claim count, with $1.2M in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does MATTHEW REEDY, MD prescribe most often?
Based on 2023 Medicare Part D data, MATTHEW REEDY, MD's most frequently prescribed drugs include Clobetasol Propionate, Ketoconazole, Triamcinolone Acetonide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MATTHEW REEDY, MD accept Medicare?
MATTHEW REEDY, MD appears in CMS Medicare data with 1,871 Part D claims and 707 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MATTHEW REEDY, MD's credentials?
MATTHEW REEDY, MD's NPI is 1346635406 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology